Franklin Resources Inc Centessa Pharmaceuticals PLC Transaction History

Franklin Resources Inc

$330 Billion
Q1 2025

A detailed history of Franklin Resources Inc transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Franklin Resources Inc holds 2,541,999 shares of CNTA stock, worth $34.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,541,999

Previous 2,308,546 10.11%

Holding current value

$34.1 Million

Previous $38.7 Million 5.47%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$14.38 - $19.03 $3.36 Million - $4.44 Million	233,453 Added 10.11%	2,541,999 $36.6 Million
Q4 2024 Feb 12, 2025	BUY	$15.04 - $18.67 $90,240 - $112,020	6,000 Added 0.26%	2,308,546 $38.7 Million
Q3 2024 Nov 12, 2024	BUY	$8.58 - $16.99 $9.83 Million - $19.5 Million	1,145,823 Added 99.06%	2,302,546 $36.8 Million
Q1 2024 May 13, 2024	BUY	$6.73 - $12.2 $275,297 - $499,053	40,906 Added 3.67%	1,156,723 $13.1 Million
Q4 2023 Feb 09, 2024	BUY	$5.52 - $8.03 $1.56 Million - $2.28 Million	283,469 Added 34.06%	1,115,817 $8.88 Million
Q4 2022 Feb 10, 2023	SELL	$3.05 - $4.19 $1,781 - $2,446	-584 Reduced 0.07%	832,348 $2.58 Million
Q2 2022 Aug 11, 2022	BUY	$3.18 - $9.85 $686,972 - $2.13 Million	216,029 Added 35.02%	832,932 $4.06 Million
Q1 2022 May 13, 2022	BUY	$7.45 - $11.59 $308,169 - $479,420	41,365 Added 7.19%	616,903 $5.53 Million
Q4 2021 Feb 11, 2022	SELL	$10.99 - $17.54 $3.81 Million - $6.08 Million	-346,562 Reduced 37.58%	575,538 $6.48 Million
Q3 2021 Nov 12, 2021	SELL	$16.7 - $23.11 $10,020 - $13,866	-600 Reduced 0.07%	922,100 $15.4 Million
Q2 2021 Aug 13, 2021	BUY	$21.71 - $25.66 $20 Million - $23.7 Million	922,700 New	922,700 $20.5 Million

Others Institutions Holding CNTA

# of Institutions

142

Shares Held

124M

Call Options Held

163K

Put Options Held

816K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.27B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Centessa Pharmaceuticals PLC Transaction History